نتائج البحث - "Bittoni, A"

المساهمون: Di Bartolomeo, M, Niger, M, Tirino, G, Petrillo, A, Berenato, R, Laterza, Mm, Pietrantonio, F, Morano, F, Antista, M, Lonardi, S, Fornaro, L, Tamberi, S, Giommoni, E, Zaniboni, A, Rimassa, L, Tomasello, G, Sava, T, Spada, M, Latiano, T, Bittoni, A, Bertolini, A, Proserpio, I, Bencardino, Kb, Graziano, F, Beretta, G, Galdy, S, Ventriglia, J, Scagnoli, S, Spallanzani, A, Longarini, R, De Vita, F

المصدر: Targeted oncology. 13(2)

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, monoclonal, Neutropenia, Antibodies, Monoclonal, Humanized, Gastroenterology, Ramucirumab, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Stomach Neoplasms, Internal medicine, 80 and over, medicine, Clinical endpoint, antibodies, Humans, adult, aged, antibodies, monoclonal, humanized, female, humans, male, middle aged, neoplasm metastasis, retrospective studies, stomach neoplasms, Pharmacology (medical), Neoplasm Metastasis, Adverse effect, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Incidence (epidemiology), Antibodies, Monoclonal, Retrospective cohort study, Middle Aged, medicine.disease, Confidence interval, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::720ff90f4dd962f9154d5fad464c10b9Test
https://pubmed.ncbi.nlm.nih.gov/29582224Test

5

Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma

المؤلفون: Antonio Zizzi, Maristella Bianconi, Mario Scartozzi, Michela Del Prete, Luca Faloppi, Rodolfo Montironi, Luciano Burattini, Alessandro Bittoni, Cristian Loretelli, Kalliopi Andrikou, Stefano Cascinu, Riccardo Giampieri

المصدر: Oncotarget

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Vascular Endothelial Growth Factor A, Indoles, Angiogenesis, sunitinib, Angiogenesis Inhibitors, urologic and male genital diseases, angiogenesis, 0302 clinical medicine, Renal cell carcinoma, pazopanib, Medicine, Aged, 80 and over, Sulfonamides, Neovascularization, Pathologic, Sunitinib, Middle Aged, VEGF, female genital diseases and pregnancy complications, Kidney Neoplasms, 030220 oncology & carcinogenesis, Female, medicine.drug, Research Paper, medicine.medical_specialty, renal cell carcinoma, Indazoles, Genotype, Polymorphism, Single Nucleotide, Pazopanib, 03 medical and health sciences, Internal medicine, Humans, In patient, Pyrroles, Genotyping, Carcinoma, Renal Cell, Aged, Retrospective Studies, business.industry, Significant difference, medicine.disease, Surgery, First line treatment, 030104 developmental biology, Pyrimidines, Receptors, Vascular Endothelial Growth Factor, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e1307790b0f22ad1e03313516c39e98Test
http://europepmc.org/articles/PMC5122335Test

6

Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study

المؤلفون: Jinghua He, David P. Carbone, Yichen Zhong, Haojie Li, Ashwini Arunachalam, Gregory M. Lubiniecki, Ramon E. Camacho, Marisa A. Bittoni

المصدر: Clinical lung cancer. 19(5)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, Drug-Related Side Effects and Adverse Reactions, medicine.medical_treatment, Cost-Benefit Analysis, Medicare, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 030212 general & internal medicine, Neoplasm Metastasis, Lung cancer, Aged, Retrospective Studies, Aged, 80 and over, Chemotherapy, business.industry, Retrospective cohort study, medicine.disease, Prognosis, Carboplatin, Gemcitabine, United States, Survival Rate, Pemetrexed, chemistry, Docetaxel, 030220 oncology & carcinogenesis, Female, business, medicine.drug, Follow-Up Studies, SEER Program

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::050539ccc4c397e8b5db89243c7043cbTest
https://pubmed.ncbi.nlm.nih.gov/29885945Test

7

دورية أكاديمية

The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy

المؤلفون: Faloppi L., Del Prete M., Casadei Gardini A., Santini D., Silvestris N., Bianconi M., Giampieri R., Valgiusti M., Brunetti O., Bittoni A., Andrikou K., Lai E., Dessi A., Cascinu S., Scartozzi M.

المساهمون: Faloppi, L., Del Prete, M., Casadei Gardini, A., Santini, D., Silvestris, N., Bianconi, M., Giampieri, R., Valgiusti, M., Brunetti, O., Bittoni, A., Andrikou, K., Lai, E., Dessi, A., Cascinu, S., Scartozzi, M.

مصطلحات موضوعية: Adult, Aged, Antineoplastic Agents, Biliary Tract Neoplasms, Biomarkers, Tumor, Cisplatin, Deoxycytidine, Disease-Free Survival, Drug Administration Schedule, Female, Humans, Kaplan-Meier Estimate, L-Lactate Dehydrogenase, Male, Middle Aged, ROC Curve, Retrospective Studies, Severity of Illness Index, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000373855000001; volume:6; issue:1; firstpage:24136; journal:SCIENTIFIC REPORTS; http://hdl.handle.net/20.500.11768/108765Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84963804707

الإتاحة: https://doi.org/20.500.11768/108765Test
https://doi.org/10.1038/srep24136Test
https://hdl.handle.net/20.500.11768/108765Test

View record in BASE

8

دورية أكاديمية

Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients

المؤلفون: Giampieri R., Salvatore L., Del Prete M., Prochilo T., Danzeo M., Loretelli C., Loupakis F., Aprile G., MacCaroni E., Andrikou K., Bianconi M., Bittoni A., Faloppi L., Demurtas L., Montironi R., Scarpelli M., Falcone A., Zaniboni A., Scartozzi M., Cascinu S.

المساهمون: Giampieri, R., Salvatore, L., Del Prete, M., Prochilo, T., Danzeo, M., Loretelli, C., Loupakis, F., Aprile, G., Maccaroni, E., Andrikou, K., Bianconi, M., Bittoni, A., Faloppi, L., Demurtas, L., Montironi, R., Scarpelli, M., Falcone, A., Zaniboni, A., Scartozzi, M., Cascinu, S.

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000374857500001; volume:6; issue:1; firstpage:25195; journal:SCIENTIFIC REPORTS; http://hdl.handle.net/20.500.11768/108764Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84964653262

الإتاحة: https://doi.org/20.500.11768/108764Test
https://doi.org/10.1038/srep25195Test
https://hdl.handle.net/20.500.11768/108764Test

View record in BASE

9

Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy?

المؤلفون: E. Sebastiani, Michele Reni, Gianpaolo Balzano, Massimo Falconi, Alessandro Bittoni, Stefano Crippa, Stefano Partelli, Andrea Lanese, Kalliopi Andrikou, Silvia Zanon, Francesca Muffatti, Stefano Cascinu

المساهمون: Crippa, S, Bittoni, A, Sebastiani, E, Partelli, S, Zanon, S, Lanese, A, Andrikou, K, Muffatti, F, Balzano, G, Reni, M, Cascinu, S, Falconi, M

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee4d7004f5a9d1f3a0bc3eaf660a72aTest

10

Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients

المساهمون: Giampieri, R., Salvatore, L., Del Prete, M., Prochilo, T., Danzeo, M., Loretelli, C., Loupakis, F., Aprile, G., Maccaroni, E., Andrikou, K., Bianconi, M., Bittoni, A., Faloppi, L., Demurtas, L., Montironi, R., Scarpelli, M., Falcone, A., Zaniboni, A., Scartozzi, M., Cascinu, S.

المصدر: Scientific Reports
Europe PubMed Central

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Vascular Endothelial Growth Factor A, Genotyping Techniques, Pharmacogenomic Variants, Angiogenesis, Colorectal cancer, Pyridines, Vascular Endothelial Growth Factor C, Angiogenesis Inhibitors, PROGRESSION, chemistry.chemical_compound, DOUBLE-BLIND, 0302 clinical medicine, PLUS, Neoplasm Metastasis, Multidisciplinary, PLACEBO, Middle Aged, Treatment Outcome, 030220 oncology & carcinogenesis, Female, TRIAL, 1ST-LINE THERAPY, BEVACIZUMAB, INHIBITION, CARCINOMA, PHASE-3, Colorectal Neoplasms, medicine.drug, Adult, medicine.medical_specialty, Bevacizumab, Polymorphism, Single Nucleotide, Article, 03 medical and health sciences, Regorafenib, Internal medicine, Carcinoma, medicine, Humans, Genotyping, Survival analysis, Aged, Retrospective Studies, business.industry, Phenylurea Compounds, medicine.disease, Receptors, Fibroblast Growth Factor, Survival Analysis, 030104 developmental biology, chemistry, Immunology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::030d65ac05e02b9c6970050b8ea91692Test
http://hdl.handle.net/11568/828173Test

تنقيح النتائج